Ludwig Cancer Research engages leading scientists and clinicians in an integrated effort to understand and confront the challenge of cancer. The Oxford Branch is based at the University of Oxford, UK and benefits from excellent links with the global Ludwig Cancer Research and local Oxford research communities.
Ludwig Oxford Branch researchers are investigating all stages of cancer, from the risk of disease through to new treatment opportunities. Our research groups are interested in the signalling pathways that influence cancer initiation and progression, with a focus on infection, inflammation and cancer epigenetics. We aim to advance cancer prevention, early diagnosis and effective treatment. Find out more about the Ludwig Oxford research groups.
News
Vacancy: Group Leader in Cancer Biology
20 April 2026
Publications
The caspase 11/gasdermin D pathway is a key driver of stress-induced neuroinflammation and behavioral dysfunction in rats.
Journal article
Tiwari S. et al, (2026), Neurochemistry international, 195
T-World Virtual Human Cardiomyocyte. I. Development, Validation, and Cell Arrhythmogenesis
Journal article
Tomek J. et al, (2026), Circulation Research
Seminars
From Stress Signals to Immune Control: Adrenergic Receptors in Tumor Immunotherapy
Thursday, 30 April 2026, 11am to 12pm
Speaker(s): Dr Jingjing Zhu
The mechanisms of adaptation in melanoma brain metastases
Thursday, 07 May 2026, 11am to 12pm
Speaker(s): Dr Arianna Baggiolini
conference
